← All companies

SER

Serina Therapeutics, Inc.

SER NYSE Pharmaceutical Preparations EDGAR ↗

$2.06

+0.02 +0.98%

Key statistics

from XBRL data in SEC filings

Market cap

$30.9M

Revenue (TTM)

$130K

Net income (TTM)

-$21.3M

EPS (TTM)

$-2.00

P/E ratio

—

Dividend yield

—

Free cash flow

-$18.0M

Cash

$24.5M

Total assets

$27.3M

Gross margin

78.5%

52-week range

$1.22 – $7.92

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jul 23, 2026 8-K Director or officer change Jul 22, 2026 8-K Amended charter or bylaws; Shareholder vote results Jun 24, 2026 8-K Results of operations (earnings release) May 14, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Director or officer change; Amended charter or bylaws Apr 21, 2026 10-K/A Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release) Mar 25, 2026 10-K Fiscal year ended 2025-12-31 Mar 25, 2026 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Mar 23, 2026 8-K Other events Jan 28, 2026 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Jan 15, 2026 8-K Other events Dec 10, 2025 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Shareholder vote results Nov 12, 2025 8-K Other events Nov 3, 2025 8-K Other events Oct 6, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Sep 15, 2025 8-K Regulation FD disclosure Sep 9, 2025 8-K Other events Aug 25, 2025 8-K Amended charter or bylaws Aug 22, 2025 8-K Results of operations (earnings release) Aug 11, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Regulation FD disclosure Jul 29, 2025 8-K Item 5.08; Regulation FD disclosure; Other events Jul 1, 2025 8-K Director or officer change; Amended charter or bylaws; Regulation FD disclosure May 22, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Entered a material agreement; Other events Apr 29, 2025 8-K Regulation FD disclosure Apr 15, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Apr 14, 2025 8-K Regulation FD disclosure Apr 7, 2025 8-K Results of operations (earnings release) Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Regulation FD disclosure Mar 24, 2025 8-K Director or officer change; Regulation FD disclosure Feb 12, 2025 8-K Regulation FD disclosure Feb 3, 2025 8-K Director or officer change Jan 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 6, 2025